The Growth Differentiation Factor 5 (GDF5) core promoter polymorphism is not associated with knee osteoarthritis in the greek population

Journal of Orthopaedic Research

Volumn 26, Issue 1, 2008, Pages 136-140

  Tsezou, Aspasia ^a,b   Satra, Maria ^a   Oikonomou, Pagona ^a   Bargiotas, Konstantinos ^a   Malizos, Konstantinos N ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Greek Caucasian population; OA; SNP

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 5;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GREECE; HUMAN; IDIOPATHIC DISEASE; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 38049028332     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20464     Document Type: Article

References (29)

1. Hunter DJ, March L, Sambrook PN. 2002. Knee osteoarthritis: the influence of environmental factors. Clin Exp Rheumatol 20:93-100.
2. Peach CA, Carr AJ, Loughlin J. 2005. Recent advances in the genetic investigation of osteoarthritis. Trends Mol Med 11:186-191.
3. Dieppe PA, Lohmander LS. 2005. Pathogenesis and management of pain in osteoarthritis. Lancet 365:965-973.
4. Peach CA, Carr AJ, Loughlin J. 2005. Recent advances in the genetic investigation of osteoarthritis. Trends Mol Med 11:186-191.
5. Zeng Q, Li X, Choi L, et al. 2006. Recombinant growth/differentiation factor-5 stimulates osteogenic differentiation of fat-derived stromal cells in vitro. Connect Tissue Res 47:264-270.
6. Nishitoh H, Ichijo H, Kimura M, et al. 1996. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352.
7. Mikic B, Battaglia TC, Taylor EA, et al. 2002. The effect of growth/differentiation factor-5 deficiency on femoral composition and mechanical behavior in mice. Bone 30:733-737.
8. Nickel J, Kotzsch A, Sebald W, et al. 2005. A single residue of GDF-5 defines binding specificity to BMP receptor IB. J Mol Biol 349:933-947.
9. Mikic B, Clark RT, Battaglia TC, et al. 2004. Altered hypertrophic chondrocyte kinetics in GDF-5 deficient murine tibial growth plates. J Orthop Res 22:552-556.
10. Miyamoto Y, Mabuchi A, Shi D, et al. 2007. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39:529-533.
11. Gauderman WJ. 2002. Sample size requirements for matched casecontrol studies of gene environment interaction. Stat Med 21:35-50.
12. Gauderman WJ. 2003. Candidate gene association studies for a quantitative trait, using parent offspring trios. Genet Epidemiol 25:327-338.
13. Peach CA, Carr AJ, Loughlin J. 2005. Recent advances in the genetic investigation of osteoarthritis. Trends Mol Med 11:186-191.
14. Loughlin J. 2005. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med 7:1-12.
15. Helgadottir A, Manolescu A, Helgason A, et al. 2006. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 38:68-74.
16. Francis-West PH, Abdelfattah A, Chen P, et al. 1999. Mechanisms of GDF-5 action during skeletal development. Development 126:1305-1315.
17. Storm EE, Huynh TV, Copeland NG, et al. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGFb-superfamily. Nature 368:639-643.
18. Thomas JT, Lin K, Nandedkar M, et al. 1996. A human chondrodysplasia due to a mutation in a TGF-b superfamily member. Nat Genet 12:315-317.
19. Zeng Q, Li X, Beck G, et al. 2007. Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells in vitro. Bone 40:374-381.
20. Hatakeyama Y, Tuan RS, Shum L. 2004. Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem 91:1204-1217.
21. Kizawa H, Kou I, Iida A, et al. 2005. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 37:138-144.
22. Mustafa Z, Dowling B, Chapman K, et al. 2005. Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population. Arthritis Rheum 52:3502-3526.
23. Kaliakatsos M, Tzetis M, Kanavakis E, et al. 2006. Asporin and knee osteoarthritis in patients of Greek origin. Osteoarthritis Cartilage 14:609-611.
24. Rodriguez-Lopez J, Pombo-Suarez M, Liz M, et al. 2006. Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians. Arthritis Res Ther 8:R55.
25. Jiang Shi D, Yi L, Ikegawa S, et al. 2006. Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J Hum Genet 51:1068-1072.
26. Spector TD, Reneland RH, Mah X, et al. 2006. Association between a variation in LRCH1 and knee osteoarthritis. Arthritis Rheum 54:524-532.
27. Snelling S, Sinsheimer JS, Carr A, et al. 2007. Genetic association analysis of LRCH1 as an osteoarthritis susceptibility locus LR. Rheumatology 46:250-252.
28. Loughlin J, Sinsheimer JS, Carr A, et al. 2006. The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population. Osteoarthritis Cartilage 14:295-298.
29. Mototani H, Mabuchi A, Saito S, et al. 2005. A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum Mol Genet 14:1009-1017.